Emmanuel Antonarakis

ASSOCIATE PROFESSOR

20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Emmanuel Antonarakis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Androgens Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

A New Molecular Taxonomy to Predict Immune Checkpoint Inhibitor Sensitivity in Prostate Cancer

Antonarakis, E., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Prostatic Neoplasms

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer

McHugh, D., Eisenberger, M., Heath, E. I., Bruce, J., Danila, D. C., Rathkopf, D. E., Feldman, J., Slovin, S. F., Anand, B., Chu, R., Lackey, J., Reyno, L., Antonarakis, E. & Morris, M. J., Jan 1 2019, In : Investigational New Drugs.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Maximum Tolerated Dose
Antibodies
Fatigue

A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer

Paller, C., Piana, D., Eshleman, J., Riel, S., Denmeade, S. R., Isaacsson Velho, P., Rowe, S., Pomper, M. G., Antonarakis, E., Luo, J. & Eisenberger, M., Jan 1 2019, In : Prostate. 79, 14, p. 1597-1603 7 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Circulating Neoplastic Cells
Therapeutics
Castration
Prostate-Specific Antigen

Blocking the PD-1/PD-L1 axis in advanced prostate cancer: Are we moving in the right direction?

Fay, A. P. & Antonarakis, E., Mar 1 2019, In : Journal of Threatened Taxa. 7, S7.

Research output: Contribution to journalEditorial

prostatic neoplasms
cancer

Clinical implications of mismatch repair deficiency in prostate cancer

Sedhom, R. & Antonarakis, E., Jul 1 2019, In : Future Oncology. 15, 20, p. 2395-2411 17 p.

Research output: Contribution to journalReview article

Prostatic Neoplasms
Immunotherapy
Tumor-Infiltrating Lymphocytes
Microsatellite Instability
Neoplasm Grading